Please try another search
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was founded in 2016 and is based in Littleton, Colorado.
Name | Age | Since | Title |
---|---|---|---|
Michael Gelb | - | 2021 | Member of Medical & Clinical Advisory Board |
Cecilia Wu | - | - | Co-Chair of Medical & Clinical Advisory Board |
Matthew Thompson | 61 | 2020 | Independent Director |
Ralph E. Green | 83 | 2020 | Independent Director |
R. Kirk Huntsman | 65 | 2016 | Co-Founder, Chairman of the Board & CEO |
Jon Caulfield | - | 2021 | Member of Medical & Clinical Advisory Board |
Clete A. Kushida | - | 2021 | Co-Chair of Medical & Clinical Advisory Board |
Tammarie Heit | - | 2021 | Member of Medical & Clinical Advisory Board |
Seth Heckman | - | - | Member of Medical & Clinical Advisory Board |
Anja B. Krammer | 55 | 2020 | Independent Director |
Mark F. Lindsay | 59 | 2020 | Independent Director |
Leonard Jay Sokolow | 66 | 2020 | Independent Director |
Lindsay Williams | - | - | Member of Medical & Clinical Advisory Board |
Edward J. Zuckerberg | - | 2021 | Member of Medical & Clinical Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review